Susan Talbot

1.5k total citations
31 papers, 541 citations indexed

About

Susan Talbot is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Susan Talbot has authored 31 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 7 papers in Surgery. Recurrent topics in Susan Talbot's work include Occupational and environmental lung diseases (4 papers), Bone health and treatments (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Susan Talbot is often cited by papers focused on Occupational and environmental lung diseases (4 papers), Bone health and treatments (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Susan Talbot collaborates with scholars based in United States, United Kingdom and Switzerland. Susan Talbot's co-authors include Robert N. Taub, Tom Treasure, J. Adam Tooze, David Bevan, Panny Kallis, Mary Hesdorffer, Mary Louise Keohan, Andrea B. Troxel, Mark Galantowicz and Mary Lou Keohan and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Susan Talbot

27 papers receiving 523 citations

Peers

Susan Talbot
Omid Jazaeri United States
Vitoon Chinswangwatanakul Thailand
Ioannis Bramis Greece
Murat Ünlü Türkiye
Noriaki Matsui Japan
Joseph A. Caprini United States
Nurcan Başar Türkiye
Sun Jin Park South Korea
Gerard Abood United States
M. Smith Australia
Omid Jazaeri United States
Susan Talbot
Citations per year, relative to Susan Talbot Susan Talbot (= 1×) peers Omid Jazaeri

Countries citing papers authored by Susan Talbot

Since Specialization
Citations

This map shows the geographic impact of Susan Talbot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Talbot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Talbot more than expected).

Fields of papers citing papers by Susan Talbot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Talbot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Talbot. The network helps show where Susan Talbot may publish in the future.

Co-authorship network of co-authors of Susan Talbot

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Talbot. A scholar is included among the top collaborators of Susan Talbot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Talbot. Susan Talbot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hendrickson, Barbara A., et al.. (2024). How Aggregate Safety Assessment Planning Supports Investigational New Drug Safety Reporting Decisions. Therapeutic Innovation & Regulatory Science. 58(4). 579–590.
3.
Wells, Christine L., et al.. (2023). An Overview of Current Statistical Methods for Implementing Quality Tolerance Limits. Therapeutic Innovation & Regulatory Science. 58(2). 273–284. 3 indexed citations
4.
Moos, Roger von, Jean-Jacques Body, Evangelos Terpos, et al.. (2018). Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study. Journal of bone oncology. 10. 49–56. 3 indexed citations
5.
Body, Jean‐Jacques, et al.. (2017). Systematic review and meta-analysis on the proportion of patients with breast cancer who develop bone metastases. Critical Reviews in Oncology/Hematology. 115. 67–80. 54 indexed citations
6.
Talbot, Susan, et al.. (2016). Gastrointestinal issues in cystic fibrosis: a lifetime of disease. Gastrointestinal Nursing. 14(5). 39–44.
7.
Hallgreen, Christine E., Shahrul Mt‐Isa, A Lieftucht, et al.. (2015). Literature review of visual representation of the results of benefit–risk assessments of medicinal products. Pharmacoepidemiology and Drug Safety. 25(3). 238–250. 18 indexed citations
8.
Corte, Tamera J., Stephen J. Wort, Susan Talbot, et al.. (2012). Elevated nocturnal desaturation index predicts mortality in interstitial lung disease.. PubMed. 29(1). 41–50. 37 indexed citations
9.
Corte, Tamera J., Susan Talbot, Stephen J. Wort, et al.. (2009). Predicting outcomes in interstitial lung disease. Thorax. 64(Suppl 4). A5–A7. 1 indexed citations
10.
Hesdorffer, Mary, John A. Chabot, Mary Louise Keohan, et al.. (2008). Combined Resection, Intraperitoneal Chemotherapy, and Whole Abdominal Radiation for the Treatment of Malignant Peritoneal Mesothelioma. American Journal of Clinical Oncology. 31(1). 49–54. 42 indexed citations
11.
Tiersten, Amy, Susan Talbot, Linda T. Vahdat, et al.. (2003). A Phase II trial of docetaxel and estramustine in patients with refractory metastatic breast carcinoma. Cancer. 97(3). 537–544. 11 indexed citations
12.
Talbot, Susan, Cathryn Rankin, Robert N. Taub, et al.. (2003). High‐dose ifosfamide with mesna and granuloctye–colony‐stimulating factor (recombinant human G‐CSF) in patients with unresectable malignant mesothelioma. Cancer. 98(2). 331–336. 3 indexed citations
13.
Talbot, Susan, Mary Louise Keohan, Mary Hesdorffer, et al.. (2003). A phase II trial of temozolomide in patients with unresectable or metastatic soft tissue sarcoma. Cancer. 98(9). 1942–1946. 64 indexed citations
14.
Savage, David G., Charles S. Hesdorffer, Daniel F. Heitjan, et al.. (2003). Combined Fludarabine and Rituximab for Low Grade Lymphoma and Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 44(3). 477–481. 24 indexed citations
15.
Dutoit, Valérie, Robert N. Taub, Kyriakos P. Papadopoulos, et al.. (2002). Multiepitope CD8+ T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting. Journal of Clinical Investigation. 110(12). 1813–1822. 9 indexed citations
16.
Talbot, Susan, Robert N. Taub, Mary Lou Keohan, et al.. (2002). Combined heart and lung transplantation for unresectable primary cardiac sarcoma. Journal of Thoracic and Cardiovascular Surgery. 124(6). 1145–1148. 62 indexed citations
17.
18.
19.
Higgins, George L., et al.. (1991). Pediatric poisoning from over-the-counter imidazoline-containing products. Annals of Emergency Medicine. 20(6). 655–658. 31 indexed citations
20.
Talbot, Susan. (1970). Atrial function in man.. BMJ. 1(5695). 567.4–567.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Omid Jazaeri Breakdown of academic impact, for papers by Vitoon Chinswangwatanakul Breakdown of academic impact, for papers by Ioannis Bramis Breakdown of academic impact, for papers by Murat Ünlü Breakdown of academic impact, for papers by Noriaki Matsui Breakdown of academic impact, for papers by Joseph A. Caprini Breakdown of academic impact, for papers by Nurcan Başar Breakdown of academic impact, for papers by Sun Jin Park Breakdown of academic impact, for papers by Gerard Abood Breakdown of academic impact, for papers by M. Smith
Rankless by CCL
2026